INMB vs UNH · rev $50.0K vs P/E 30, rev $112.03B
INmune Bio Inc (INMB) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
INMB currently screens at market cap $33.5M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the INMB and UNH stock pages for the full models.
Not investment advice.